Michelle E Kruijshaar
Affiliation: Erasmus MC
Country: The Netherlands
- Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center studyJuna M de Vries
Department of Neurology and Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Orphanet J Rare Dis 7:73. 2012..We investigated whether it alters the course of disease, and also identified potential prognostic factors...
- The breast cancer related burden of morbidity and mortality in six European countries: the European Disability Weights projectMichelle E Kruijshaar
Department of Public Health, Erasmus University Rotterdam, Rotterdam, The Netherlands
Eur J Public Health 14:141-6. 2004..The burden of breast cancer expressed in Disability Adjusted Life Years (DALYs) was compared for six European countries and its sensitivity to different sources of variation examined...
- Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall biasMichelle Elisabeth Kruijshaar
Department of Public Health, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands
Eur J Epidemiol 20:103-11. 2005..This method is useful in the absence of direct measurement, but also showed that direct estimates are underestimated by recall bias and by the cross-sectional setting...
- Has the burden of depression been overestimated?Michelle E Kruijshaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, 3000 DR Rotterdam, The Netherlands
Bull World Health Organ 83:443-8. 2005..To investigate whether high estimates of the burden of depression could be attributed to an overestimation of disability weights (reflecting more severe disability)...
- Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence dataMark van Blankenstein
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
Scand J Gastroenterol 42:308-17. 2007..The aim of this study was to create models estimating the BO population fitting each of these three hypotheses, in order to select the most plausible hypothesis and to gain insight into the Danish BO population...
- Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groupsMarie Louise Essink-Bot
Department of Public Health, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
Qual Life Res 16:1309-18. 2007..We investigated the determinants of patients' reported burden of upper gastrointestinal (GI) endoscopy by comparing data from three patient groups...
- The use of models in the estimation of disease epidemiologyMichelle E Kruijshaar
Department of Public Health, Erasmus University Rotterdam, Rotterdam, Netherlands
Bull World Health Organ 80:622-8. 2002..To explore the usefulness of incidence-prevalence-mortality (IPM) models in improving estimates of disease epidemiology...
- A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagusMichelle E Kruijshaar
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
BMC Med Res Methodol 9:31. 2009..We conducted a labelled discrete choice experiment with realistic choices to investigate patients' trade-offs between the expected health gains and the burden of testing in surveillance of Barrett esophagus (BE)...
- Evidence-based guidelines, time-based health outcomes, and the Matthew effectMarie Louise Essink-Bot
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Eur J Public Health 17:314-7. 2007..The time-based model maximises numbers of life years gained by treating the young and non-smokers, or 'the one who has will be given more' (Matthew 25:29). We explored practical consequences of risk- or time-based allocation...
- Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as lowMichelle E Kruijshaar
Department of Public Health, Erasmus MC University Medical Center Rotterdam, The Netherlands
Gastrointest Endosc 65:26-30. 2007..The risk of developing esophageal adenocarcinoma (EAC) for patients with Barrett's esophagus (BE) is approximately 0.5% per year...